Summary:
Click image to enlargeTrial is being investigated on the effectiveness and safety of AXA1125, an investigation product which is not approved and is a new drug that is administered as a drink for patients with the diagnosis of Non-Alcoholic Steatohepatitis.
Qualified Participants Must:
• You will need to be 18 years of age of above
•
Have recently undergone a liver biopsy
•
Have been diagnosed with Non-Alcoholic Steatohepatitis
Qualified Participants May Receive:
Will receive compensation for travel and time, study medication, and excellent care by study staff.